T cell-intrinsic role for Nod2 in protection against Th17-mediated uveitis.
Ruth J NapierEllen J LeeMichael P DaveyEmily E VanceJoão M FurtadoPaige E SnowKimberly A SamsonSydney J LashleyBrieanna R BrownReiko HoraiMary J MattapallilBiying XuMichelle C CalleganLuke S UebelhoerChristina L LancioniRichard K VeheBryce A BinstadtJustine R SmithRachel R CaspiHolly L RosenzweigPublished in: Nature communications (2020)
Mutations in nucleotide-binding oligomerization domain-containing protein 2 (NOD2) cause Blau syndrome, an inflammatory disorder characterized by uveitis. The antimicrobial functions of Nod2 are well-established, yet the cellular mechanisms by which dysregulated Nod2 causes uveitis remain unknown. Here, we report a non-conventional, T cell-intrinsic function for Nod2 in suppression of Th17 immunity and experimental uveitis. Reconstitution of lymphopenic hosts with Nod2-/- CD4+ T cells or retina-specific autoreactive CD4+ T cells lacking Nod2 reveals a T cell-autonomous, Rip2-independent mechanism for Nod2 in uveitis. In naive animals, Nod2 operates downstream of TCR ligation to suppress activation of memory CD4+ T cells that associate with an autoreactive-like profile involving IL-17 and Ccr7. Interestingly, CD4+ T cells from two Blau syndrome patients show elevated IL-17 and increased CCR7. Our data define Nod2 as a T cell-intrinsic rheostat of Th17 immunity, and open new avenues for T cell-based therapies for Nod2-associated disorders such as Blau syndrome.